Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the FoF Domestic median (128 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 11 Mar 2011 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Gold history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Nippon India Gold Savings Fund |
|---|---|
| 11 Mar 2011 | ₹100.00 |
| 23 Jun 2012 | ₹139.26 |
| 06 Oct 2013 | ₹138.52 |
| 19 Jan 2015 | ₹124.26 |
| 03 May 2016 | ₹131.18 |
| 16 Aug 2017 | ₹122.53 |
| 30 Nov 2018 | ₹127.19 |
| 14 Mar 2020 | ₹171.82 |
| 27 Jun 2021 | ₹191.30 |
| 10 Oct 2022 | ₹203.17 |
| 23 Jan 2024 | ₹244.55 |
| 07 May 2025 | ₹374.30 |
| 20 Aug 2026 | ₹590.68 |
| Metric | Nippon India · Regular · IDCW NAV ₹59.27 High risk ★★★☆☆ | Category median FoF Domestic · 128 funds |
|---|---|---|
| +56.43% | +5.71% | |
| +36.76% | +10.60% | |
| +25.30% | +7.04% | |
| +15.79% | +8.12% | |
| +12.19% | +8.44% | |
| +32.29% | — | |
| +8.91% | +9.37% | |
| +8.47% | +8.64% | |
| +8.30% | +8.30% | |
| Risk | ||
| 21.91% | 13.12% | |
| 1.38 | 0.40 | |
| 1.99 | 0.57 | |
| -27.40% | -18.33% | |
| Gold | — | |
| -2.16% | +0.09% | |
| 1.08 | 0.95 | |
| 99.3% | 92.9% | |
| 100.8% | 81.4% | |
| 0.25% | 0.58% | |
| ₹7,262Cr | ₹372.62Cr | |
| Up to 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 3% | 13% | |
| Himanshu Mange | — | |
| 11 Mar 2011 | — | |
| — | — | |
| — | — | |
| 0.0% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.